Skip to main content
Media center
Media center

Media center

Hero Press Release
Press release
Nov 25, 2025
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00...

Read more

Featured news
Featured news
Press release
Nov 25, 2025
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00...

Read more

Press release
Nov 20, 2025
Solventum Announces Agreement to Acquire Acera Surgical

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million...

Read more

Press release
Nov 20, 2025
Solventum Announces $1 Billion Share Repurchase Program

Solventum (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to purchase up to $1 billion of the Company's outstanding common...

Read more

More »

Press releases
Press release
Nov 25, 2025
Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

Solventum (NYSE: SOLV) announced today that management will participate in a fireside chat at the Piper Sandler Healthcare Conference on Tuesday, Dec. 2, 2025, beginning at approximately 10:00...

Read more

Press release
Nov 20, 2025
Solventum Announces Agreement to Acquire Acera Surgical

Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space, a part of the broader regenerative tissue matrices category within acute care settings, a $900 million...

Read more

Press release
Nov 20, 2025
Solventum Announces $1 Billion Share Repurchase Program

Solventum (NYSE: SOLV) announced today its Board of Directors has approved a share repurchase program, which authorizes the Company to purchase up to $1 billion of the Company's outstanding common...

Read more

See all news

Resources
Brand images

Download

Solventum logos

Download

Fact sheet

Download

Contact Media Relations

These contacts are intended only for the media. If you are not a member of the media, please call 1-855-423-6725 (1-855-HC FOR ALL).

Contact us